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ABSTRACT 
The  PC12  clone  is a  noradrenergic  cell line  derived  from a  rat  pheochromocy- 
toma.  In culture  medium  containing  horse  serum,  PC12  cells  undergo  mitosis; 
when  nerve  growth  factor  (NGF)  is  included  in  the  medium,  the  cells  cease 
multiplication and extend neurites.  It is shown here:  (a) that PC12 cells are not 
viable  in  serum-free  medium.  When  serum  is withdrawn,  90%  of the  cells die 
within  4-6 days and 99%  by 2-3 wk. (b) If NGF is added at the time of serum 
withdrawal,  the cells undergo one doubling and remain viable for at least 1 mo. 
(c) Addition of NGF to cultures after more than 2 days in serum-free conditions 
results in maintenance of surviving cells, but not in an increase in cell number. (d) 
NGF also induces neurite outgrowth from PC12 cells in serum-free medium. (e) 
NGF-treated cells exhibit  much less cell-cell and  neurite-neurite  aggregation  in 
the absence than in the presence of serum.  (f) The apparent minimum level of 
2.5S NGF required for PC12 survival and morphological differentiation in serum- 
free medium is about 10 ng/ml (-0.4  nM). (g) Withdrawal of NGF in serum-free 
conditions  results  in  degeneration  of  neurites  and  loss  of  cell  viability.  (h) 
Experiments with camptothecin demonstrate that the effects of NGF on survival 
and neurite outgrowth may be uncoupled and suggest that the survival effects are 
transcriptionally  independent.  The  present  results  also  suggest  that  PC12  cells 
have a requirement for NGF (similar to that of normal sympathetic neurons) and 
that serum may substitute for this requirement.  In addition, the present system of 
maintaining  a  highly  differentiated  cell  line  in  a  chemically  defined  medium 
suggests certain experimental opportunities. 
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Nerve growth factor protein  (NGF) is known to 
have a  number of effects on  responsive sympa- 
thetic and sensory ganglionic neurons (for reviews, 
see  references  18,  30,  and  34).  These  effects 
include  stimulation  of  neurite  outgrowth  (18), 
increase in cell size  (18) and induction of certain 
enzymes  involved  in  neurotransmitter  synthesis 
(26). In addition, NGF also appears to play a role 
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example, sympathetic and responsive sensory neu- 
rons fail to  survive and extend  neurites in vitro 
unless exogenous  NGF  is  added  to  the  culture 
medium (5, 16). Also, treatment of neonates with 
anti-serum to NGF results in the near-total loss of 
their sympathetic neurons (17). 
Several studies have shown that cultured adre- 
nal medullary pheochromocytoma  cells  can  also 
respond  to  NGF  by  outgrowth  of  neuron-like 
processes  (27,  28).  A  clonal cell line known as 
PC12 has been established (8) from a transplant- 
able rat pheochromocytoma (32), and this line has 
been particularly promising as a model with which 
to study the  mechanism(s) of action of NGF.  In 
culture medium  containing horse  serum but not 
NGF, PC12 cells undergo mitosis (8) and display 
a  number  of  properties  of  adrenal  chromaffin 
cells, such  as the  presence  of intracellular chro- 
maffin  granules  and  the  abilities  to  synthesize, 
store,  take up, and release catecholamines (8, 9, 
11,  13).  The  cells  also  synthesize,  store,  and 
release acetylcholine (10, 24).  Under such condi- 
tions,  PC12  cells  do  not  extend  neurites  (8). 
Within a  few days after nanogram levels of NGF 
are added to the culture medium, PC 12 cells cease 
mitosis, extend long, branching neurites (8), be- 
come  electrically  excitable  and  exhibit  a  large 
increase in chemosensitivity to acetylcholine (7). 
Such  effects  are  reversible.  Within several  days 
after withdrawal of NGF from PC12 cultures, the 
neurites disintegrate  and  mitotic activity recom- 
mences (8).  Such studies have suggested that, in 
response to  NGF treatment,  PC12  cells take  on 
many  of  the  properties  of  normal  sympathetic 
neurons (7, 8). 
One particular contrast of PC12  cells with re- 
sponsive normal neurons is that  while the pheo- 
chromocytoma cells respond to NGF, they do not 
appear  to  require  it  for  their  survival in serum- 
containing medium.  In  the  present  study,  how- 
ever,  we  demonstrate  that  PC12  cells  are  not 
viable in serum-free medium and that under such 
conditions NGF prevents cell death and promotes 
neurite outgrowth. 
MATERIALS  AND  METHODS 
Cell Culture 
Pc12 rat pheochromocytoma cells (250-350 genera- 
tions after isolation) were maintained in cell culture as 
previously  described  (8, 9). For subculture, cells were 
mechanically dislodged from the dish by trituration. For 
all experiments, cells (in 1.5 ml of medium) were plated 
onto 35-ram tissue culture dishes which had been previ- 
ously coated with rat tail collagen  (8, 9). Culture me- 
dium was  exchanged  three times weekly.  Mouse 2.5S 
nerve  growth  factor  was  prepared  according to  the 
method of Bocchini and Angeletti (4). In some experi- 
ments, the culture medium was supplemented with 1 /.~g/ 
ml eamptothecin (kindly supplied by the Drug Synthesis 
and Chemistry Branch, Division of Cancer Treatment, 
National Cancer Institute). 
Cell Counts and Determination  of  Proportion 
of Process-Bearing Cells 
Cell number per culture was determined by either of 
two  means.  In  most  cases,  the  culture  medium  was 
removed and the cells were brought into suspension by 
treatment with trypsin (0.1% DIFCO 1:250, for 15-30 
min at 37~  and counted in a hemacytometer. In some 
experiments, cell number was determined by strip counts 
(31)  of approx.  2%  of the  surface  area  of the  dish. 
Application of both methods to the same cultures gave 
values which agreed to within -+10%. For each sample 
analyzed, at least  1,000 cells were counted. In several 
experiments, viability was confirmed by the use of trypan 
blue (>95 % of cells counted excluded the dye). 
Proportions of process-bearing  cells per culture were 
determined by strip counts as previously described  (8, 
31).  Processes  were scored  only if their length was at 
least twice the cell body diameter (>20 /~m in length). 
At least 300 ceils were scored per dish. 
RESULTS 
Serum Requirement for Survival of PC12 
Cells in the Absence of NGF 
Under their previously described growth condi- 
tions  (8)  in  serum-containing  medium  (85% 
RPMI  1640,  5%  fetal  calf  serum,  10%  horse 
serum, and no NGF), PC12 cells show excellent 
viability and growth (Fig.  1). In order to observe 
the effect of serum-free conditions on PC12 cells, 
the  growth  medium  was  removed,  the  cultures 
were washed three times with serum-free medium 
(RPMI  1640),  and  then  either  (a)  the  cultures 
were  re-fed with serum-free medium, or (b)  the 
cells were detached and subcultured on new dishes 
in  serum-free  medium,  or  (c)  the  cells  were 
maintained for  1-5  days  in  serum-free  medium 
and then subcultured on new dishes in serum-free 
medium. In each case,  exposure to medium free 
of serum and of NGF resulted in immediate loss 
of cell viability (Figs 1, 6, and 7). In five separate 
experiments, approx. 90% of the cells died within 
4-6 days and approx.  99%  within 2-3 wk. Such 
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~(~u~E  1  Effect of NGF on survival of PC12 cells in 
serum-flee  medium.  Sister  cultures  were  maintained 
with serum-containing medium until day zero. The cul- 
tures  were  then  washed  three  times  with  serum-free 
medium and fed with either serum-containing medium 
(triangles),  serum-free  medium  (closed  circles)  or  se- 
rum-free medium plus NGF (open circles).  On  days 2 
and  5,  some  cultures  were  changed  from  serum-free 
medium to serum-free medium plus NGF.  Cell counts 
arc averages of determinations on duplicate cultures. 
effects  occurred  at  initial cell  densities ranging 
from  very  sparse  to  very crowded  (i.e.  105-107 
cells/35-mm dish).  Cell death  was  accompanied 
by cell disintegration, which in turn was reflected 
by the  appearance of membrane fragments and 
insoluble debris in the culture medium. Although 
PC12  cells are  viable in suspension, living cells 
were  not  observed  floating  in  the  medium  of 
serum-free cultures and, hence, loss of cell num- 
ber  was  not  due  to  cell  detachment  from  the 
substrate.  Also,  in  contrast  to  observations re- 
ported  for  clonal murine C1300  neuroblastoma 
cells (25),  withdrawal of serum from  PC12  cul- 
tures did not induce neurite outgrowth. 
Effect of NGF on Viability and Morphologic 
Differentiation of PC12 Cells in 
Serum-Free Medium 
Addition of 2.5S  NGF (50 ng/ml or  -2  nM, 
unless otherwise specified) to serum-free cultures 
produced profound effects on PC12 cell viability. 
When NGF was added at the time of change-over 
to serum-free conditions (see Fig. 1 for the results 
of one such experiment), the cell number under- 
went  approximately one  doubling and  then  re- 
mained stable for at least 6 wk. When NGF was 
added to cultures after several days of treatment 
with serum-free medium alone, the  loss of cells 
immediately ceased, and the population remained 
at near-constant levels (Fig.  1).  Cell number did 
not increase, however, when NGF was added to 
cultures  that  had  been  previously  exposed  to 
serum-free  medium for  2-7  days.  In all experi- 
ments,  examination of  the  cultures  after  addi- 
tion of NGF revealed no evidence of continued 
cell  death  (i.e.,  there  was  no  debris  of  the 
type  present  in  serum-free  cultures  maintained 
without NGF). This suggests that maintenance of 
cell number by NGF was  due  to  continued cell 
viability rather  than  to  an  equilibrium between 
cell death and cell division. 
In  addition to  preventing the  death  of  PC12 
cells  in  serum-free  medium, NGF also  induced 
their  morphological  differentiation. Fig.  2  (see 
also  Fig.  7)  shows  the  rate  of  appearance  of 
neurites in serum-free cultures after addition of 
NGF. Note that the lag time for first appearance 
of neurites was substantially decreased in cultures 
which  were  exposed  to  serum-free  medium  for 
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FIGURE 2  Rate  of appearance  of neurites  in serum- 
free cultures of PC12 cells maintained in the presence 
(open circles) or absence (closed circles) of NGF. Cul- 
ture conditions are as described in legend of Fig. 1. 
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absence or (B) presence of serum. Bar, 100/~m. x250. 
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morphology of PC12  cells treated  with NGF in 
the absence of serum (Fig. 3A) was in many ways 
comparable  to  that  of cultured  primary sympa- 
thetic neurons (cf.  reference 20). The cell bodies 
extended  long (>100  /zm)  neurites which were 
varicose and which showed  typical growth-cone- 
like extensions. However, in contrast to sympa- 
thetic  neurons and  to  PC12  cells  treated  with 
NGF  in  the  presence  of  serum  (Fig.  3B),  the 
neurites of cells in serum-free medium were finer 
and showed much less formation of small bundles 
or fascicles.  Also, the cell bodies of NGF-treated 
cells showed appreciably less tendency to aggre- 
gate in serum-free cultures and formed more of a 
monolayer than in the presence of serum. 
The effect of NGF in serum-free medium was 
also tested on several other cell lines which do not 
show evident responses to the factor in the pres- 
ence  of  serum.  These  lines included C6  glioma 
cells (3), 3T3 fibroblasts (29), T28 neuroblastoma 
X sympathetic ganglion cell hybrids (12), and an 
NGF-unresponsive rat cell line developed by us 
and designated as F-4. In each case, NGF did not 
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Fi6utuE  4  Reversibility of the effect of NGF on PC12 
cell survival in serum-free  medium. Culture conditions 
were as indicated in legend of Fig. 1. On days 2, 5, and 
9,  NGF  was  withdrawn  from  certain cultures  as indi- 
cated. This was achieved by washing (three times) and 
refeeding the cultures with medium free of both NGF 
and serum. 
affect  either cell viability or  morphology  in the 
absence of serum. Thus, NGF does not appear to 
be a general survival factor for all cell lines. 
Reversibility  of the Effect of NGF on 
Survival and Differentiation  of PC12 
Cells in the Absence of Serum 
When  NGF  was  withdrawn  from  serum-free 
cultures of PC12 ceils after various times of treat- 
ment, cells began to die within 24 h  (Fig. 4). In 
addition, removal of NGF also resulted in loss of 
neurites by disintegration. As shown in Fig. 5, this 
loss of processes was even more rapid than loss of 
cell number. 
Dose-Response Relationship  for the 
Effects o  f N G F in Serum-Free  Cultures 
PC12 cells were exposed to serum-free medium 
for 2 days, and then equal numbers of cells were 
subcultured in the  presence of various levels of 
2.5S  NGF.  After  1  wk  of treatment,  both  cell 
number and  proportion of  process-bearing cells 
were  determined for each  culture. As shown in 
Fig.  6,  the  minimal level of  NGF required  for 
both maximal maintenance of survival and mor- 
phologic differentation was on the order of 10 ng/ 
ml  (~0.4  nM).  This  corresponds  to  approx.  1 
10C 
0 
8C 
0 
6a 
40 
ae 
2O 
(~  2  4  6  10  12  14 
DAYS  IN  SERUM-FREE  MEDIUM 
FIGURE 5  Reversibility of the effect of NGF on PC12 
cell survival and morphological differentiation in serum- 
free medium. Experimental conditions are as indicated 
in legends of Figs. 1 and 4. 
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Dose-response relationship for the effects of 
NGF on survival (upper panel; dosed circles) and mor- 
phological differentiation (lower panel; open circles) of 
PC12  cells  in  serum-free  medium.  Serum-free  sister 
cultures were prepared by subculturing cells which had 
been previously maintained in serum-free medium for 2 
days.  Pairs  of cultures were then treated  with various 
levels of NGF. After 7 days, the cultures were analyzed 
for  proportion  of  process-bearing  cells  and  for  cell 
number. Data are averages of determinations on dupli- 
cate plates. 
Biological  Unit/ml  as  defined  by  the  classical 
biological  assay  for  NGF  (18).  However,  since 
NGF is known to readily adsorb  to surfaces (23), 
particularly  in  the  absence  of  carrier  proteins 
(such  as  those  in  serum),  the  above  figures  are 
probably an overestimate of the true minimal level 
of  NGF  required  for  survival  and  morphologic 
differentiation  of  PC12  cells  in  the  absence  of 
serum. 
Dissociation of the Effects of NGF on 
PC12 Cell Survival and Neurite Outgrowth 
in the Absence of Serum 
Camptothecin  is  a  drug  which  is  known  to 
reversibly block synthesis of messenger and ribo- 
somal RNA in a  variety of mammalian cell types 
(cf.  references  1,  15,  and  33).  Experiments with 
PC12  cells maintained  in  the  presence  of serum 
have revealed that low levels of camptothecin can 
block  NGF-induced  neurite  outgrowth  without 
affecting  cell  viability  (D.  Burstein  and  L.  A. 
Greene.  Manuscript  in  press),  as  well  as  block 
NGF-stimulated  synthesis  of  certain  cell  pro- 
teins  (21).  It  was  therefore  of  interest  to  ob- 
serve  the  effects  of  this  drug  on  PC12  cells 
treated  with  NGF  in  the  absence  of serum.  As 
shown  in  Fig.  7,  treatment  of  PC12  cells  with 
camptothecin (1 ~g/ml) in serum-free medium did 
not retard cell loss in the absence of NGF. More- 
over, the drug did not affect the ability of NGF to 
maintain cell viability in serum-free medium for at 
least  1  wk.  However,  as  shown  in  Fig.  7,  in 
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FIGURE 7  Effect of camptothecin (1  /~g/ml) on NGF- 
induced survival (upper frame) and morphological differ- 
entiation  (lower  frame)  of  PC12  cells  in  serum-free 
medium.  Serum-free sister cultures  were  prepared  by 
subculturing  cells which had been previously maintained 
in serum-free medium for 2 days.  Cultures were treated 
with either NGF (open triangles), NGF plus camptothe- 
cin (closed triangles), camptothecin (closed circles),  or 
no additives (open circles). After various lengths of time, 
as indicated, duplicate cultures were assayed for propor- 
tion of process-hearing cells and for cell number. At the 
time  indicated  by  the  arrow,  the  medium  of cultures 
containing  both  NGF and  camptothecin  was  replaced 
with medium containing only NGF. Data are averages 
of determinations on duplicate plates. 
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alone, those also treated with camptothecin failed 
to extend processes. As a control for cell viability 
and  function,  NGF-induced  neurite  outgrowth 
commenced when the camptothecin was removed 
from the culture medium. Such findings suggest in 
part that it is possible to uncouple the effects of 
NGF on PC12 cell survival from those on morpho- 
logic differentiation. 
DISCUSSION 
With respect to their dependence on serum and 
on NGF, PC12 cells are, in some respects, similar 
to  and  yet  different  from  normal  sympathetic 
neurons. In the presence of horse serum (but not 
of fetal calf serum), PC12 cells survive and multi- 
ply in the absence of exogenously supplied NGF. 
Under  such  culture  conditions,  PC12  cells can, 
however,  respond  to  NGF  by  cessation  of  cell 
division and  neurite outgrowth  (8).  It  has been 
shown  here  that  PC12  cells  do  not  survive  in 
serum-free medium, but that they will do so when 
NGF is present. In contrast, normal sympathetic 
neurons  require  NGF  for  their  survival  when 
plated in vitro, even in the presence of serum (5, 
16).  Moreover, sympathetic and responsive sen- 
sory neurons can also be maintained in vitro (at 
least for limited periods of time) by NGF under 
serum-free conditions (14, 19, 20). 
The  ability  of  serum-treated  PC12  cells  (in 
contrast  with  normal  sympathetic  neurons)  to 
survive and divide in the absence of NGF is not 
surprising in light of their being tumor cells. PC12 
cells thus appear to be supported by serum fac- 
tor(s)  which  cannot  maintain  survival of young 
postmitotic sympathetic neurons. From this point 
of view, it may not be that NGF can substitute for 
the PC12  cell serum requirement, but rather that 
serum  can  substitute  for  the  PC12  ceU  NGF 
requirement.  Hence,  when  serum  is  removed, 
PC12  cells show the same requirement for NGF 
as do normal sympathetic neurons.  The  compo- 
nents of serum responsible for PC12 cell survival 
and  growth  appear  to  be  neither  universal nor 
nonspecific, since PC12  cultures cannot  be  sup- 
ported  by  fetal  calf  serum  (8).  Furthermore, 
such serum factors do not appear to be identical 
to NGF. For example, the level of horse serum 
which maintains PC12 cultures does not stimulate 
neurite  outgrowth  from  PC12  cells  or  survival 
of  sympathetic  neurons.  Also,  anti-NGF  does 
not  affect  viability  in  serum-containing  PC12 
cultures  (P.  Calissano  and  L.  A.  Greene,  un- 
published observations). 
It has been  hypothesized that  PC12  cells may 
be  analogous  to  a  developmental  precursor  of 
normal  sympathetic neurons  (7,  8,  28).  In  this 
regard, the behavior of PC12 cells may resemble 
that  of  in  vivo  embryonic  cells.  In  particular, 
recent evidence suggests that catecholamine-con- 
taining sympathetic ganglion cells maintained  in 
vitro from certain embryonic stages can respond 
to NGF, but do not require it for survival (6). 
The mechanism(s) by which NGF maintains the 
viability of PC12  cells in the absence of serum is 
not  prr  clear.  The  present  findings,  how- 
ever,  do  appear to  exclude several possibilities. 
First, it is evident that this phenomenon does not 
require ancillary factors present in serum such as 
hormones,  steroids, or macromolecules. Second, 
since PC12  cells may undergo at  least one  dou- 
bling when NGF is introduced along with serum- 
free  medium,  the  survival effect of the factor is 
not due to trapping of the cells in a  "protected" 
part  of the  cell cycle.  Third,  survival does  not 
appear to be a consequence of neurite outgrowth. 
The effect of NGF on PC12 cell viability occurs at 
times  well  before  neurite  outgrowth  is  evident. 
Moreover,  NGF  maintains  survival  even  when 
neurite outgrowth  is blocked by treatment  with 
camptothecin. 
In  the  present  experiments  with  serum-free 
medium, both survival and  neuronal  differentia- 
tion of PC12 cells exhibited similar dose-response 
curves with  respect to  NGF concentration  (Fig. 
6).  This suggests that  these  two  effects of NGF 
may be mediated via shared initial steps. Among 
these could be interaction of NGF with a common 
receptor site. In this regard, it is of interest that 
the apparent I~ (0.2-0.3 nM) for binding of NGF 
with a  receptor on  mammalian ganglionic mem- 
branes  (2)  is  comparable  in  magnitude  to  the 
minimally required levels of NGF in the present 
experiments. On the other hand, the observation 
that camptothecin uncouples the effects of NGF 
on  survival  and  neurite  outgrowth  implies  that 
subsequent  steps in  the  mediation of these  two 
effects may follow independent or divergent path- 
ways. 
The present experiments employing camptothe- 
tin raise an additional point regarding the molec- 
ular level at which NGF promotes cell survival. 
Camptothecin  has  been  shown  in  several  cell 
systems to  interfere selectively with  synthesis of 
messenger and ribosomal RNA (1,  15,  33), and 
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block  NGF-induced  neurite  outgrowth  (D.  Bur- 
stein  and  L.  Greene.  Manuscript  in  press) 
and  selective  induction  of  synthesis  of  several 
proteins (21).  Such findings suggest that the sur- 
vival-promoting effect of NGF is independent of 
RNA transcription. This notion is consistent with 
the previous observation that NGF promotes sur- 
vival of cultured chick embryo ganglionic neurons 
even in  the  presence of levels of actinomycin  D 
which block greater than 90% of incorporation of 
radiolabeled uridine into TCA-precipitable mate- 
rial (22). Confirmation of this point in the present 
system, however, awaits a detailed analysis of the 
effect of camptothecin on PC12 cell RNA synthe- 
sis. 
Aside  from  supporting  PC12  cell  viability,  a 
second major effect of NGF described here was to 
promote  neurite  outgrowth  in  a  chemically  de- 
fined  medium.  This observation raises  the  point 
that  initiation  and  long-term  maintenance  of 
NGF-promoted fiber outgrowth from  PC12  cells 
does  not  require a  continuous exogenous supply 
of  additional  factors  such  as  steroids,  peptide 
hormones,  or  macromolecules  or  of  potential 
membrane  components  found  in  serum  such  as 
complex  lipids.  Another  interesting  aspect  of 
PC12  cultures  maintained  with  NGF in  the  ab- 
sence  of  serum  was  that  the  ceils  display  finer 
neurites,  near-absence of fiber fasciculation, and 
much  less  tendency  to  form  cell-cell aggregates 
than  do cells in NGF-treated cultures which con- 
tain  serum.  Such  observations  suggest  that  the 
effect of NGF on morphology and cell-cell inter- 
action in PC12 cultures may be profoundly influ- 
enced  by  environmental  factors  such  as  serum. 
Furthermore, in preliminary experiments we have 
noted  similar  morphologic effects  in  serum-free 
cultures  of  normal  sympathetic  neurons,  while 
Luduefia (19) has reported that neurons in serum- 
free  cultures  of  chick  embryo  sensory  ganglia 
display alterations in morphology and interaction 
with substrate.  Thus,  the  influence of serum  on 
cell interactions of NGF-responsive cells is appar- 
ently not limited to the PC12 line. 
One last aspect which merits brief discussion is 
the  experimental implications of the  observation 
that  clonal  PC12  cells  may  be  maintained  in 
serum-free medium. Among the potential uses of 
this  system  is  to  study  in  a  chemically  defined 
environment (a) the mechanism(s) by which NGF 
promotes cell survival; (b) the effects of addition 
of known  amounts of defined substances  on var- 
ious  differentiated  neuronal  properties;  (c)  the 
effects of serum  and  serum  components  on  cell 
morphology and cell-cell interaction; (d) the test- 
ing and identification of serum components which 
can  substitute  for  the  NGF  requirement  of  a 
neoplastic cell line. 
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